Trevena Inc (TRVN)

[couldbebetter]

What I find strange is the lack of any solid plan for who will sell the
newly approved product. The past investor presentations alluded to JV
partners...suddenly, that part is no longer part of the newest investor
presentation.

Whoever, or whatever will be selling Olinvyk had better be decided
soon with a scheduled 1st quarter launch. Will TRVN hire its own
sales team? Will they announce a JV partnership for the US? Will
some BP decide its time to swoop in and acquire the company? Most
confounding is the fact that an FDA approved product with a $1 billion
plus peak sales potential would have such a low market cap as what
exists today.

Important to keep in mind that the call options here indicate that
a move to the upside is expected by someone. Could something be
pressuring the price down to get management to accept a deal of
some type? Why no mention (that I have seen) of a plan for Europe?
I asked the IR guy about that on Friday and he was stumped...Very
strange that TRVN has no plan for Olinvyk in Europe. If I am wrong
about this please let me know!